Clinical TrialsSearch results
Number of results: 709
Other
- A phase II trial of concurrent chemoradiotherapy with 5-FU plus cisplatin for resectable squamous cell carcinoma of cervical esophagus
- cervical esophageal cancer
- National Cancer Center Hospital
- 2009-01-05
Other
- A phase II trial of FOLFIRI combined with hyperthermia as second-line therapy of unresectable colon cancer with liver metastases
- Colon cancer patients with liver metastases who had been treated by FOLFOX as first-line therapy
- Molecular Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine
- 2009-06-01
Other
- A phase II trial of pre-operative chemoradiotherapy followed by surgical resection in Pancoast tumors: initial report of Japan Clinical Oncology Group trial (JCOG 9806)
- pulmonary neoplasm
- Japan Clinical Oncology Group(JCOG)
- 2005-07-28
Other
- A phase II, multicenter, study for newly diagnosed glioblastomas using boron neutron capture therapy, additional X-ray treatment and chemotherapy
- Newly-diagnosed glioblastoma
- Dept. of Neurosurgery, Osaka Medical College
- 2009-09-01
Other
- A phase II/III clinical study of R442(Pegylated Interferon alfa-2a) for patients with chronic hepatitis B.
- chronic hepatitis B
- CHUGAI PHARMACEUTICAL CO.LTD.
- 2007-04-26
Completed
- A PHASE III OPEN-LABEL EXTENSION STUDY TO EVALUATE LONG-TERM SAFETY AND EFFICACY OF PRM-151(rhPTX-2) IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF)
- Idiopathic pulmonary fibrosis
- Shimoda Yukiko
- 2021-12-26
Other
- A phase III randomised trial of lobectomy versus limited resection (segmentectomy) for small (2 cm or less) peripheral non-small cell lung cancer (JCOG0802/WJOG4607L)
- small (2 cm or less) peripheral non-small cell lung cancer
- Japan Clinical Oncology Group(JCOG)
- 2009-08-10
Other
- A Phase III Randomized, Multicenter Study Comparing Irinotevan and Cisplatin (IP) with Amrubicin and Cisplatin (AP) for the Treatment of Extensive-Stage Small-Cell Lung Cancer: (JCOG0509)
- extensive-disease small cell lung cancer
- Japan Clinical Oncology Group(JCOG)
- 2007-05-22
Other
- A Phase III Study Comparing Etoposide and Cisplatin (EP) with Irinotecan and Cisplatin (IP) following EP plus Concurrent Accelerated Hyperfractionated Thoracic Irradiation (EP/TRT) for the Treatment of Limited-Stage Small-Cell Lung Cancer (EP/TRT-IPIII): JCOG0202-MF
- Limited-Stage Small-Cell Lung Cancer
- Japan Clinical Oncology Group(JCOG)
- 2005-08-30
Other
- A Phase III Study Comparing Irinotecan, Cisplatin and Etoposide (PEI) with Nogitecan for the Treatment of Relapsed Small-Cell Lung Cancer (JCOG0605)
- Sensitive relpased small-cell lung cancer
- Japan Clinical Oncology Group(JCOG)
- 2007-09-20